Skip to main content
. 2007 Nov 5;153(2):358–366. doi: 10.1038/sj.bjp.0707565

Figure 2.

Figure 2

Concentration–response effects of JWH015 (a) and JWH133 (b) on synovial blood flow. The selective CB2 receptor antagonist AM630 (10−8 mol) was unable to block the vasodilator effect of JWH015, but significantly attenuated the hyperaemic response of JWH133 (***P<0.001, **P<0.01 vs control; two-way ANOVA followed by Bonferroni post hoc test; n=11–38). Data are presented as mean percent change in perfusion±s.e.m.